Department of Health and Human Services Release New Buprenorphine Guidelines


Playback Speed

No me gusta!

The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.

tom f. -

Hi Reuben!
it's good to hear you again. (it's tom fiero from merced).
thank you for this
I took the 8 hour course.
our problem in Merced, ca is largely methamphetamines

Reuben Strayer (@emupdates) -

great, Tom!

amphetamine addiction is super challenging.

Nicholas F. -

I submitted my paperwork from the SAMHSA site the same night this was released. Took a few weeks to get my X-Waiver. I was very happy and have tried twice to prescribe now (Opiates/Opiods are not as frequent of an issue in Hawaii).

Both times my scripts have been declined. Apparantly, as I am not associated with any substance abuse clinics, I am only listed as being able to prescribe for "pain control" not for substance abuse prevention. Is this a mistake or the way the new X-Waiver guidelines are written?

Is there anyone else with this issue? I am going to contact the SAMHSA to se how I can fix this.

Reuben Strayer (@emupdates) -

If you are submitting the prescription with your DEA-X number (it starts with the letter X), and you are getting that feedback from your pharmacy, the problem is the pharmacy.

Any DEA-registered provider can prescribe buprenorphine for pain control; X-waivered docs are able to prescribe for OUD. You do not need to be affiliated with any clinic.

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.

To download files, you need to subscribe.

Sign up today for full access to all episodes.
EM:RAP 2021 May 10th Breaking News: HHS Releases New Buprenorphine Guidelines Full episode audio for MD edition 3:22 min - 4 MB - M4A